Transoral laser microsurgery ± adjuvant therapy versus chemoradiotherapy for stage III and IVA oropharyngeal squamous cell carcinoma: Preliminary comparison of early swallowing outcomes

Head and Neck

Volumn 37, Issue 10, 2015, Pages 1488-1494

  O'Hara, James ^a   Cosway, Benjamin ^a   Muirhead, Colin ^b   Leonard, Nicola ^c   Goff, Diane ^c   Patterson, Joanne ^b,c  

^a NEWCASTLE UNIVERSITY   (United Kingdom)

^b NEWCASTLE UNIVERSITY   (United Kingdom)

^c SUNDERLAND ROYAL HOSPITAL   (United Kingdom)

Author keywords

chemoradiotherapy; oropharyngeal squamous cell carcinoma; swallowing; transoral surgery

Indexed keywords

CISPLATIN; MITOMYCIN;

ADULT; ARTICLE; ASSESSMENT OF HUMANS; CANCER ADJUVANT THERAPY; CANCER STAGING; CARBON DIOXIDE LASER; CHEMORADIOTHERAPY; COHORT ANALYSIS; COMPARATIVE STUDY; FEMALE; FUNCTION TEST; HUMAN; LASER SURGERY; MAJOR CLINICAL STUDY; MALE; MD ANDERSON DYSPHAGIA INVENTORY; MICROSURGERY; MIDDLE AGED; MULTIPLE CYCLE TREATMENT; OROPHARYNX CARCINOMA; OUTCOME ASSESSMENT; PERFORMANCE STATUS SCALE; PRIORITY JOURNAL; RADIATION DOSE; SWALLOWING; TRANSORAL LASER MICROSURGERY; WATER SWALLOW TEST; AGED; CARCINOMA, SQUAMOUS CELL; DEGLUTITION DISORDERS; LOW LEVEL LASER THERAPY; MULTIMODALITY CANCER THERAPY; OROPHARYNGEAL NEOPLASMS; PATHOLOGY; PROCEDURES; TREATMENT OUTCOME;

ADULT; AGED; CARCINOMA, SQUAMOUS CELL; CHEMORADIOTHERAPY; COMBINED MODALITY THERAPY; DEGLUTITION; DEGLUTITION DISORDERS; FEMALE; HUMANS; LASER THERAPY; MALE; MICROSURGERY; MIDDLE AGED; NEOPLASM STAGING; OROPHARYNGEAL NEOPLASMS; TREATMENT OUTCOME;

EID: 84941743483     PISSN: 10433074     EISSN: 10970347     Source Type: Journal    
DOI: 10.1002/hed.23790     Document Type: Article

References (21)

1. Parsons JT, Mendenhall WM, Stringer SP, et al., Squamous cell carcinoma of the oropharynx: surgery, radiation therapy, or both. Cancer 2002; 94: 2967-2980.
2. Haughey BH, Hinni ML, Salassa JR, et al., Transoral laser microsurgery as primary treatment for advanced-stage oropharyngeal cancer: a United States multicenter study. Head Neck 2011; 33: 1683-1694.
3. Ang KK, Harris J, Wheeler R, et al., Human papillomavirus and survival of patients with oropharyngeal cancer. N Engl J Med 2010; 363: 24-35.
4. Wilson JA, Carding PN, Patterson JM,. Dysphagia after nonsurgical head and neck cancer treatment: patients' perspectives. Otolaryngol Head Neck Surg 2011; 145: 767-771.
5. Frowen J, Cotton S, Corry J, Perry A,. Impact of demographics, tumor characteristics, and treatment factors on swallowing after (chemo)radiotherapy for head and neck cancer. Head Neck 2010; 32: 513-528.
6. Logemann JA, Pauloski BR, Rademaker AW, et al., Swallowing disorders in the first year after radiation and chemoradiation. Head Neck 2008; 30: 148-158.
7. Langendijk JA, Doornaert P, Rietveld DHF, Verdonck-de Leeuw IM, Leemans CR, Slotman BJ,. A predictive model for swallowing dysfunction after curative radiotherapy in head and neck cancer. Radiother Oncol 2009; 90: 189-195.
8. Patterson JM, McColl E, Carding PN, Hildreth AJ, Kelly C, Wilson JA,. Swallowing in the first year after chemoradiotherapy for head and neck cancer: clinician- and patient-reported outcomes. Head Neck 2014; 36: 352-358.
9. Edge SB, Byrd DR, Compton C, Fritz AG, Greene FL, Trotti A III, editors. AJCC Cancer Staging Manual. 7th ed. New York, NY: Springer; 2010.
10. Robinson M, Schache A, Sloan P, Thavaraj S,. HPV specific testing: a requirement for oropharyngeal squamous cell carcinoma patients. Head Neck Pathol 2012; 6 Suppl 1: S83-S90.
11. Rich JT, Milov S, Lewis JS Jr, Thorstad WL, Adkins DR, Haughey BH,. Transoral laser microsurgery (TLM) +/- adjuvant therapy for advanced stage oropharyngeal cancer: outcomes and prognostic factors. Laryngoscope 2009; 119: 1709-1719.
12. Steiner WA,. Endoscopic laser surgery of the upper aerodigestive tract. Stuttgart: Thieme; 2000.
13. Chen AY, Frankowski R, Bishop-Leone J, et al., The development and validation of a dysphagia-specific quality-of-life questionnaire for patients with head and neck cancer: the M. D. Anderson dysphagia inventory. Arch Otolaryngol Head Neck Surg 2001; 127: 870-876.
14. List MA, Ritter-Sterr C, Lansky SB,. A performance status scale for head and neck cancer patients. Cancer 1990; 66: 564-569.
15. Patterson JM, McColl E, Carding PN, Kelly C, Wilson JA,. Swallowing performance in patients with head and neck cancer: a simple clinical test. Oral Oncol 2009; 45: 904-907.
16. Burnip E, Owen SJ, Barker S, Patterson JM,. Swallowing outcomes following surgical and non-surgical treatment for advanced laryngeal cancer. J Laryngol Otol 2013; 127: 1116-1121.
17. Wu MC, Chang YC, Wang TG, Lin LC,. Evaluating swallowing dysfunction using a 100-ml water swallowing test. Dysphagia 2004; 19: 43-47.
18. Jensen K, Lambertsen K, Torkov P, Dahl M, Jensen AB, Grau C,. Patient assessed symptoms are poor predictors of objective findings. Results from a cross sectional study in patients treated with radiotherapy for pharyngeal cancer. Acta Oncol 2007; 46: 1159-1168.
19. Adelstein DJ, Ridge JA, Brizel DM, et al., Transoral resection of pharyngeal cancer: summary of a National Cancer Institute Head and Neck Cancer Steering Committee Clinical Trials Planning Meeting, November 6-7, 2011, Arlington, Virginia. Head Neck 2012; 34: 1681-1703.
20. More YI, Tsue TT, Girod DA, et al., Functional swallowing outcomes following transoral robotic surgery vs primary chemoradiotherapy in patients with advanced-stage oropharynx and supraglottis cancers. JAMA Otolaryngol Head Neck Surg 2013; 139: 43-48.
21. Roe JW, Carding PN, Rhys-Evans PH, et al., Patient-reported swallowing outcomes following IMRT for head and neck cancer. In: British Association of Head and Neck Oncologists April 26, 2013. London: Royal College of Physicians; 2013.